When is it appropriate to treat children with social anxiety, pharmacologically?

Avigal Snir, Danielle M. Moskow, Stefan G. Hofmann

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)2423-2426
Number of pages4
JournalExpert Opinion on Pharmacotherapy
Volume22
Issue number18
DOIs
StatePublished - Dec 2021
Externally publishedYes

Bibliographical note

Funding Information:
Dr. Hofmann receives financial support from the Alexander von Humboldt Foundation, NIH/NIMH (R01MH099021, U01MH108168), and the James S. McDonnell Foundation. He receives compensation for his work as editor from SpringerNature, and as an advisor from the Palo Alto Health Sciences, Otsuka Pharmaceuticals, Jazz Pharmaceuticals. and for his work as a Subject Matter Expert from John Wiley & Sons, Inc., Wolters Kluwer, and SilverCloud Health, Inc. He also receives royalties and payments for his editorial work from various publishers.

Funding Information:
Dr. Hofmann was?supported for this work by the James S. McDonnell Foundation via a Collaborative Activity Award (ID: 220020479).

Funding

Dr. Hofmann receives financial support from the Alexander von Humboldt Foundation, NIH/NIMH (R01MH099021, U01MH108168), and the James S. McDonnell Foundation. He receives compensation for his work as editor from SpringerNature, and as an advisor from the Palo Alto Health Sciences, Otsuka Pharmaceuticals, Jazz Pharmaceuticals. and for his work as a Subject Matter Expert from John Wiley & Sons, Inc., Wolters Kluwer, and SilverCloud Health, Inc. He also receives royalties and payments for his editorial work from various publishers. Dr. Hofmann was?supported for this work by the James S. McDonnell Foundation via a Collaborative Activity Award (ID: 220020479).

FundersFunder number
National Institutes of Health
National Institute of Mental HealthR01MH099021, U01MH108168
James S. McDonnell Foundation220020479
Alexander von Humboldt-Stiftung

    Cite this